Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.520
+0.080 (5.56%)
At close: Sep 26, 2025, 4:00 PM EDT
1.470
-0.050 (-3.29%)
After-hours: Sep 26, 2025, 7:53 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $93.31 million as of September 26, 2025. Its market cap has decreased by -87.48% in one year.
Market Cap
93.31M
Enterprise Value
-109.19M
1-Year Change
-87.48%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $93.31M, a decrease of -87.35%. That is a compound annual growth rate of -32.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 93.31M | -88.36% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 665.99B |
| Johnson & Johnson | 425.53B |
| AbbVie | 388.63B |
| UnitedHealth Group | 318.63B |
| Novo Nordisk | 259.65B |
| Novartis AG | 238.19B |
| AstraZeneca | 233.83B |
| Abbott Laboratories | 233.03B |